Development of a Prototype Lateral Flow Immunoassay (LFI) for the Rapid Diagnosis of Melioidosis

PLoS Neglected Tropical Diseases

Volumn 8, Issue 3, 2014, Pages

  Houghton, Raymond L ^a   Reed, Dana E ^b   Hubbard, Mark A ^b   Dillon, Michael J ^b   Chen, Hongjing ^a   Currie, Bart J ^c   Mayo, Mark ^c   Sarovich, Derek S ^c   Theobald, Vanessa ^c   Limmathurotsakul, Direk ^d   Wongsuvan, Gumphol ^e   Chantratita, Narisara ^f   Peacock, Sharon J ^d,g   Hoffmaster, Alex R ^h   Duval, Brea ^h   Brett, Paul J ⁱ   Burtnick, Mary N ⁱ   AuCoin, David P ^b  

^a InBios International Inc   (United States)

^b UNIVERSITY OF NEVADA SCHOOL OF MEDICINE   (United States)

^c ROYAL DARWIN HOSPITAL   (Australia)

^d MAHIDOL UNIVERSITY   (Thailand)

^e Sappasitthiprasong Hospital   (Thailand)

^f MAHIDOL OXFORD TROPICAL MEDICINE RESEARCH UNIT   (Thailand)

^g UNIVERSITY OF CAMBRIDGE   (United Kingdom)

^h NATIONAL CENTER FOR EMERGING AND ZOONOTIC INFECTIOUS DISEASES   (United States)

ⁱ UNIVERSITY OF SOUTH ALABAMA COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

MONOCLONAL ANTIBODY;

ANTIGEN CAPTURE ENZYME LINKED IMMUNOSORBENT ASSAY; ANTIGEN SPECIFICITY; ARTICLE; BACTERIUM CULTURE; BURKHOLDERIA MALLEI; BURKHOLDERIA PSEUDOMALLEI; CONTROLLED STUDY; CROSS REACTION; ENZYME LINKED IMMUNOSORBENT ASSAY; HUMAN; IMMUNOASSAY; LIMIT OF DETECTION; MELIOIDOSIS; SEQUENCE ANALYSIS; URINALYSIS; WESTERN BLOTTING;

ANTIBODIES, BACTERIAL; ANTIBODIES, MONOCLONAL; ANTIGENS, BACTERIAL; AUSTRALIA; BURKHOLDERIA PSEUDOMALLEI; HUMANS; IMMUNOCHROMATOGRAPHY; MELIOIDOSIS; POINT-OF-CARE SYSTEMS; POLYSACCHARIDES, BACTERIAL; SENSITIVITY AND SPECIFICITY; THAILAND;

EID: 84897401176     PISSN: 19352727     EISSN: 19352735     Source Type: Journal    
DOI: 10.1371/journal.pntd.0002727     Document Type: Article

References (39)

1. Wiersinga WJ, Currie BJ, Peacock SJ, (2012) Melioidosis. N Engl J Med 367: 1035-1044.
2. Currie BJ, Ward L, Cheng AC, (2010) The epidemiology and clinical spectrum of melioidosis: 540 cases from the 20 year Darwin prospective study. PLoS neglected tropical diseases 4: e900.
3. Limmathurotsakul D, Wongratanacheewin S, Teerawattanasook N, Wongsuvan G, Chaisuksant S, et al. (2010) Increasing incidence of human melioidosis in Northeast Thailand. Am J Trop Med Hyg 82: 1113-1117.
4. Sirisinha S, Anuntagool N, Dharakul T, Ekpo P, Wongratanacheewin S, et al. (2000) Recent developments in laboratory diagnosis of melioidosis. Acta Trop 74: 235-245.
5. Wongsuvan G, Limmathurotsakul D, Wannapasni S, Chierakul W, Teerawattanasook N, et al. (2009) Lack of correlation of Burkholderia pseudomallei quantities in blood, urine, sputum and pus. Southeast Asian J Trop Med Public Health 40: 781-784.
6. Wuthiekanun V, Limmathurotsakul D, Wongsuvan G, Chierakul W, Teerawattanasook N, et al. (2007) Quantitation of B. Pseudomallei in clinical samples. Am J Trop Med Hyg 77: 812-813.
7. Limmathurotsakul D, Jamsen K, Arayawichanont A, Simpson JA, White LJ, et al. (2010) Defining the true sensitivity of culture for the diagnosis of melioidosis using Bayesian latent class models. PLoS One 5: e12485.
8. Wuthiekanun V, Dance DA, Wattanagoon Y, Supputtamongkol Y, Chaowagul W, et al. (1990) The use of selective media for the isolation of Pseudomonas pseudomallei in clinical practice. J Med Microbiol 33: 121-126.
9. Inglis TJ, Merritt A, Chidlow G, Aravena-Roman M, Harnett G, (2005) Comparison of diagnostic laboratory methods for identification of Burkholderia pseudomallei. J Clin Microbiol 43: 2201-2206.
10. Nuti DE, Crump RB, Dwi Handayani F, Chantratita N, Peacock SJ, et al. (2011) Identification of circulating bacterial antigens by in vivo microbial antigen discovery. mBio Aug 16;2 (4) ().
11. AuCoin DP, (2012) In vivo microbial antigen discovery: finding the 'needle in the haystack'. Expert Rev Mol Diagn 12: 219-221.
12. Perry MB, MacLean LL, Schollaardt T, Bryan LE, Ho M, (1995) Structural characterization of the lipopolysaccharide O antigens of Burkholderia pseudomallei. Infect Immun 63: 3348-3352.
13. Ashdown LR, (1979) An improved screening technique for isolation of Pseudomonas pseudomallei from clinical specimens. Pathology 11: 293-297.
14. Peterman JH (1991) Immunochemistry of solid-phase immunoassay; Butler JE, editor. Boca Raton, FL.: CRC Press, Inc.
15. AuCoin DP, Crump RB, Thorkildson P, Nuti DE, LiPuma JJ, et al. (2010) Identification of Burkholderia cepacia complex bacteria with a lipopolysaccharide-specific monoclonal antibody. Journal of medical microbiology 59: 41-47.
16. Propst KL, Mima T, Choi KH, Dow SW, Schweizer HP, (2010) A Burkholderia pseudomallei deltapurM mutant is avirulent in immunocompetent and immunodeficient animals: candidate strain for exclusion from select-agent lists. Infect Immun 78: 3136-3143.
17. (2013): AOAC International.
18. Heiss C, Burtnick MN, Wang Z, Azadi P, Brett PJ, (2012) Structural analysis of capsular polysaccharides expressed by Burkholderia mallei and Burkholderia pseudomallei. Carbohydrate research 349: 90-94.
19. Chantratita N, Wuthiekanun V, Limmathurotsakul D, Thanwisai A, Chantratita W, et al. (2007) Prospective clinical evaluation of the accuracy of 16S rRNA real-time PCR assay for the diagnosis of melioidosis. Am J Trop Med Hyg 77: 814-817.
20. Limmathurotsakul D, Peacock SJ, (2011) Melioidosis: a clinical overview. British medical bulletin 99: 125-139.
21. Richardson LJ, Kaestli M, Mayo M, Bowers JR, Tuanyok A, et al. (2012) Towards a rapid molecular diagnostic for melioidosis: Comparison of DNA extraction methods from clinical specimens. Journal of microbiological methods 88: 179-181.
22. Appassakij H, Silpapojakul KR, Wansit R, Pornpatkul M, (1990) Diagnostic value of the indirect hemagglutination test for melioidosis in an endemic area. Am J Trop Med Hyg 42: 248-253.
23. Kanaphun P, Thirawattanasuk N, Suputtamongkol Y, Naigowit P, Dance DA, et al. (1993) Serology and carriage of Pseudomonas pseudomallei: a prospective study in 1000 hospitalized children in northeast Thailand. J Infect Dis 167: 230-233.
24. Cheng AC, Wuthiekanun V, Limmathurotsakul D, Chierakul W, Peacock SJ, (2008) Intensity of exposure and incidence of melioidosis in Thai children. Trans R Soc Trop Med Hyg 102 Suppl 1: S37-39.
25. Wuthiekanun V, Chierakul W, Langa S, Chaowagul W, Panpitpat C, et al. (2006) Development of antibodies to Burkholderia pseudomallei during childhood in melioidosis-endemic northeast Thailand. Am J Trop Med Hyg 74: 1074-1075.
26. Cheng AC, O'Brien M, Freeman K, Lum G, Currie BJ, (2006) Indirect hemagglutination assay in patients with melioidosis in northern Australia. Am J Trop Med Hyg 74: 330-334.
27. Tandhavanant S, Wongsuvan G, Wuthiekanun V, Teerawattanasook N, Day NP, et al. (2013) Monoclonal antibody-based immunofluorescence microscopy for the rapid identification of Burkholderia pseudomallei in clinical specimens. Am J Trop Med Hyg 89: 165-168.
28. Wuthiekanun V, Desakorn V, Wongsuvan G, Amornchai P, Cheng AC, et al. (2005) Rapid immunofluorescence microscopy for diagnosis of melioidosis. Clin Diagn Lab Immunol 12: 555-556.
29. Chantratita N, Tandhavanant S, Wongsuvan G, Wuthiekanun V, Teerawatanasuk N, et al. (2013) Rapid Detection of Burkholderia pseudomallei in Blood Cultures Using a Monoclonal Antibody-Based Immunofluorescent Assay. Am J Trop Med Hyg 89: 971-972.
30. Ekpo P, Rungpanich U, Pongsunk S, Naigowit P, Petkanchanapong V, (2007) Use of protein-specific monoclonal antibody-based latex agglutination for rapid diagnosis of Burkholderia pseudomallei infection in patients with community-acquired septicemia. Clin Vaccine Immunol 14: 811-812.
31. Wuthiekanun V, Anuntagool N, White NJ, Sirisinha S, (2002) Short report: a rapid method for the differentiation of Burkholderia pseudomallei and Burkholderia thailandensis. Am J Trop Med Hyg 66: 759-761.
32. Samosornsuk N, Lulitanond A, Saenla N, Anuntagool N, Wongratanacheewin S, et al. (1999) Short report: evaluation of a monoclonal antibody-based latex agglutination test for rapid diagnosis of septicemic melioidosis. Am J Trop Med Hyg 61: 735-737.
33. Anuntagool N, Naigowit P, Petkanchanapong V, Aramsri P, Panichakul T, et al. (2000) Monoclonal antibody-based rapid identification of Burkholderia pseudomallei in blood culture fluid from patients with community-acquired septicaemia. J Med Microbiol 49: 1075-1078.
34. Bartlett JG, (2011) Diagnostic tests for agents of community-acquired pneumonia. Clin Infect Dis 52 Suppl 4: S296-304.
35. Jarraud S, Descours G, Ginevra C, Lina G, Etienne J, (2013) Identification of legionella in clinical samples. Methods Mol Biol 954: 27-56.
36. Price EP, Sarovich DS, Mayo M, Tuanyok A, Drees KP, et al. (2013) Within-host evolution of Burkholderia pseudomallei over a twelve-year chronic carriage infection. MBio 4.
37. Cuccui J, Milne TS, Harmer N, George AJ, Harding SV, et al. (2012) Characterization of the Burkholderia pseudomallei K96243 capsular polysaccharide I coding region. Infect Immun 80: 1209-1221.
38. Sim BM, Chantratita N, Ooi WF, Nandi T, Tewhey R, et al. (2010) Genomic acquisition of a capsular polysaccharide virulence cluster by non-pathogenic Burkholderia isolates. Genome Biol 11: R89.
39. Glass MB, Gee JE, Steigerwalt AG, Cavuoti D, Barton T, et al. (2006) Pneumonia and septicemia caused by Burkholderia thailandensis in the United States. J Clin Microbiol 44: 4601-4604.